精品久久久久久777米琪桃花,永久免费的啪啪网站免费观看浪潮,按摩师玩弄少妇到高潮,波多野结衣高清一区二区三区,狠狠狠狼鲁亚洲综合网,久久综合久久自在自线精品自,久久精品国产2020,亚洲综合色噜噜狠狠网站超清,污污污污污污污网站污,少妇脱了内裤让我添

About Us
ProfileCultureHistoryHonorsCompany
Profile

Chizhou Dongsheng Pharmaceutical Co., Ltd. is located in Dongzhi Economic Development Zone, Dongzhi County, Chizhou City, Anhui Province. It was established in 2006 with a registered capital of 70 million yuan and is mainly engaged in the production and sales of pharmaceutical intermediates and raw materials. Dongsheng Pharmaceutical is the first pharmaceutical raw material production enterprise in Dongzhi Economic Development Zone. It has obtained a total of 5 national brand approvals for raw materials, including fexofenadine hydrochloride, diammonium glycyrrhetinic acid, tiopronin, esomeprazole sodium, and naphazoline hydrochloride. Among them, fexofenadine hydrochloride has passed GMP certification, and multiple pharmaceutical intermediate products, such as linachlor, bosentan, vardenafil hydrochloride, and tadanafil, have been approved, We are in a leading position in both domestic and international markets. It has unique advantages in the production of high-end pharmaceutical intermediates and raw materials.

In 2022, Dongsheng Pharmaceutical introduced a large state-owned listed company, Jinling Pharmaceutical Co., Ltd., as the controlling shareholder, and Nanjing Aide Kaiteng Biopharmaceutical Co., Ltd. as the participating shareholder. Dongsheng Pharmaceutical has fully launched the overall planning and construction of new and old factory areas, as well as the comprehensive management project of safety and environmental protection facilities. In the future, Dongsheng Pharmaceutical will accelerate the high-quality development of Dongsheng Pharmaceutical through resource integration, relying on growth and strength.

Chizhou Dongsheng Pharmaceutical Co., Ltd.